Insider Transactions in Q3 2025 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
13,389
-23.15%
|
$468,615
$35.66 P/Share
|
|
Sep 05
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,389
+18.8%
|
$200,835
$15.52 P/Share
|
|
Sep 04
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
SELL
Open market or private sale
|
Direct |
3,523
-27.23%
|
$123,305
$35.31 P/Share
|
|
Sep 04
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
85,271
-65.73%
|
$2,984,485
$35.52 P/Share
|
|
Sep 04
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
85,271
+29.09%
|
$1,279,065
$15.51 P/Share
|
|
Sep 03
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
15,091
-25.34%
|
$528,185
$35.5 P/Share
|
|
Sep 03
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,091
+10.15%
|
$226,365
$15.51 P/Share
|
|
Sep 03
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
11,000
-22.44%
|
$374,000
$34.84 P/Share
|
|
Sep 03
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.33%
|
$187,000
$17.92 P/Share
|
|
Sep 02
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
950
-2.09%
|
$32,300
$34.28 P/Share
|
|
Sep 02
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,964
+4.15%
|
-
|
|
Sep 02
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
375
-0.98%
|
$12,750
$34.28 P/Share
|
|
Sep 02
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
774
+1.98%
|
-
|
|
Sep 02
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
900
-2.81%
|
$30,600
$34.28 P/Share
|
|
Sep 02
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,861
+5.5%
|
-
|
|
Sep 02
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
835
-1.34%
|
$28,390
$34.28 P/Share
|
|
Sep 02
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,725
+2.7%
|
-
|
|
Sep 02
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
481
-3.58%
|
$16,354
$34.28 P/Share
|
|
Sep 02
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
994
+6.9%
|
-
|
|
Sep 02
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,177
-2.76%
|
$108,018
$34.28 P/Share
|
|
Sep 02
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,569
+5.4%
|
-
|
|
Sep 01
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,022
-6.5%
|
$99,726
$33.49 P/Share
|
|
Sep 01
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,245
+4.48%
|
-
|
|
Sep 01
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,282
-10.22%
|
$141,306
$33.49 P/Share
|
|
Sep 01
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,853
+7.05%
|
-
|
|
Sep 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,920
-8.84%
|
$96,360
$33.49 P/Share
|
|
Sep 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,036
+6.09%
|
-
|
|
Sep 01
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,841
-4.49%
|
$93,753
$33.49 P/Share
|
|
Sep 01
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,872
+3.09%
|
-
|
|
Sep 01
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,819
-18.49%
|
$93,027
$33.49 P/Share
|
|
Sep 01
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,829
+12.89%
|
-
|
|
Sep 01
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,983
-9.2%
|
$362,439
$33.49 P/Share
|
|
Sep 01
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,711
+6.34%
|
-
|
|
Aug 18
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
16,200
-14.39%
|
$550,800
$34.11 P/Share
|
|
Aug 18
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+10.33%
|
$52,000
$8.83 P/Share
|
|
Aug 14
2025
|
Thomas Malley |
SELL
Open market or private sale
|
Direct |
78,233
-86.18%
|
$2,581,689
$33.09 P/Share
|
|
Aug 14
2025
|
Thomas Malley |
BUY
Exercise of conversion of derivative security
|
Direct |
78,233
+31.29%
|
$1,095,262
$15.0 P/Share
|
|
Aug 13
2025
|
Thomas Malley |
SELL
Open market or private sale
|
Direct |
50,129
-79.98%
|
$1,654,257
$33.32 P/Share
|
|
Aug 13
2025
|
Thomas Malley |
BUY
Exercise of conversion of derivative security
|
Direct |
50,129
+35.25%
|
$501,290
$10.12 P/Share
|
|
Aug 12
2025
|
Thomas Malley |
SELL
Open market or private sale
|
Direct |
49,407
-79.75%
|
$1,581,024
$32.4 P/Share
|
|
Aug 12
2025
|
Thomas Malley |
BUY
Exercise of conversion of derivative security
|
Direct |
49,407
+34.8%
|
$98,814
$2.83 P/Share
|
|
Aug 06
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
29,325
-33.81%
|
$938,400
$32.55 P/Share
|
|
Aug 06
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,325
+25.27%
|
$87,975
$3.8 P/Share
|
|
Aug 05
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
138,614
-37.16%
|
$4,574,262
$33.55 P/Share
|
|
Aug 05
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
138,614
+17.31%
|
$1,524,754
$11.43 P/Share
|
|
Aug 04
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
17,000
-33.97%
|
$544,000
$32.35 P/Share
|
|
Aug 04
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+25.36%
|
$255,000
$15.52 P/Share
|
|
Aug 04
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
18,889
-41.15%
|
$604,448
$32.89 P/Share
|
|
Aug 04
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,889
+29.16%
|
$415,558
$22.89 P/Share
|
|
Jul 30
2025
|
Kimberly J Popovits |
SELL
Exercise of conversion of derivative security
|
Direct |
64,508
-83.72%
|
$1,870,732
$29.9 P/Share
|